Online discussion for the HBV community on scientific progress in Europe towards a cure featured TherVacB’s European HBV Patient Registry
On 24th November 2021 the International Coalition for the Elimination of HBV, ICE-HBV, in partnership with Liver Patients International opened the floor to an online discussion of updates on HBV Cure Research in Europe. As part of the „B_Aware” awareness campaign about hepatitis B prevention, infection, therapy and cure research, TherVacB team member Prof. Dr. Markus Cornberg, Medical School Hannover, Germany, introduced the European HBV Patient Registry for patients living with chronic hepatitis.
Over 1.5 hours, leading scientists, researchers and clinicians have been discussing latest HBV cure-related research and scientific topics with patients, people living with HBV and the HBV community, engaging in a lively discussions with attendees.
Get the presentation slides or watch the recorded session here on YouTube and leave a comment under the video anytime.
An online lecture explores ethical benefits and challenges of social media recruitment for clinical studies.
Recruiting patients for clinical studies through social media yields ethical benefits and challenges. On 24th November 2022 at 15:00 CET, TherVacB experts in biomedical ethics, empirical research, social media, AI and digital health, Bettina M. Zimmermann and Theresa Willem, will open the floor to a brief discussion of benefits and challenges of social media recruitment for clinical studies from an ethical perspective. They will introduce a checklist for researchers to determine the suitability of social media recruitment when designing a study. In a Q&A session, they will be open to further discussing questions and comments from healthcare professionals, recruitment operators such as digital study, nurse researchers or young investigators in clinical settings.
Please register here to join the Zoom session: https://cutt.ly/TherVacB-Lecture_Register
In this lecture, Dr. Bettina M. Zimmermann and Theresa Willem, M.A., will introduce findings of their empirical and literary research carried out at the Institute of History and Ethics in Medicine, Technical University of Munich, Germany, published in a first article in the Journal of Medical Internet Research in May and September 2022.
Globally, 325 million people live with hepatitis, one of the most neglected diseases. On World Hepatitis Day 2022, the TherVacB project coordinator, Prof. Ulrike Protzer, joins the collective voices from across the world to raise awareness about Hepatitis B (HBV) and empower the HBV community. She contributes to the “The HBV Cure FAQs”, a new collection of short videos answering key questions relating to HBV cure research, by discussing: What do we need to achieve an HBV Cure? Anti-virals, immune therapries, or both?
The HBV Cure FAQs are a new tool aimed at empowering the community by equipping them with the knowledge needed to understand research for a HBV cure that is taking place for their benefit. It is a product of an international consortium of organizations, projects and expert institutions working in and around hepatitis B. The TherVacB project is honoured to be one of the organizations involved along with ICE-HBV, Hepatitis B Foundation, World Hepatitis Alliance, HepBCommunity.org, Australian Centre for Hepatitis Virology, IP-cure-B project, and the Canadian HBV Network.
Get your one-off screening for hepatitis B from your GP in Germany
Hepatitis B can be treated well at an early stage, hepatitis C can even be cured. In Germany, like in other countries and regions of the world, many people affected are unaware of their infection. Since 1st October 2021, people living in Germany are now entitled to a one-off screening from the age of 35 at no extra cost carried out by their GP. In order to detect and treat infections with hepatitis B and hepatitis C viruses as early as possible, screening for both viruses in the health check-up for people with statutory health insurance as a health insurance benefit as of 1st October. The guidelines of the German Society for Gastroenterology, Digestive and Metabolic Diseases tell doctors what they should pay attention to in screening, diagnosis and therapy. Brand new recommendations on hepatitis B virus infections are now included due to TherVacB scientists Prof. Markus Cornberg (Hannover Medical School, Germany) and Prof. Ulrike Protzer (Helmholtz Zentrum Munich, Germany) and other experts.
- In its ninth year, European Testing Week continues to encourage partner organisations in community, health care and policy in Europe to join forces this autumn to increase integrated testing efforts & promote awareness on the benefits of hepatitis and HIV testing.
- European Testing Week supports testing activities throughout the year: To find out where you can have a test for HIV, hepatitis or other sexually transmitted infections use the European Test Finder. Hundreds of testing services for viral hepatitis, HIV and STIs are registered.
- Find out more about the campaign on their website here.